BioSpace News Archive

Alnylam Pharmaceuticals, Inc. today announced new positive results from the six-month primary analysis period of the ILLUMINATE-C Phase 3 open-label study of lumasiran.

Tesis Biosciences , the leader in targeted genetic sequencing, has been selected by Pathways Health Partners (PHP), an accountable care organization (ACO) dedicated to solving the challenges facing healthcare today, to provide member practices with next-generation sequencing (NGS) testing and precision medicine services.

Sparrow Pharmaceuticals today presented new pharmacological data during a poster session and a Rapid Communications session.

HiberCell announced that it will present the background and design of two clinical trials of the Company’s therapeutic candidates, odetiglucan and HC-7366, in individual poster presentations at the 2022 Annual Meeting of the American Society of Clinical Oncology, which will be held in person and virtually on June 3-7, 2022 in Chicago, Illinois.

Conformis, Inc. announced results of a published study that investigated the characteristic shapes of knees to see if typical patient identifiers such as gender, body type, or ethnicity influence the shape of the knee joint.

RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), is pleased to announce that Dr. Arnold Lippa, the Company’s Executive Board Chairman, Chief Scientific Officer, Interim CEO and Interim President, will be an invited speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit, which will take place September 6 - 8, 2022 in Boston, MA.

Surrozen, Inc. (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced the presentation of data supporting the continued development of its lead therapeutic programs at Digestive Disease Week (DDW) 2022 in San Diego.

AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory Joint Diseases at the EULAR 2022 Congress.

Zsquare, leading developer of high-performance, single-use endoscopes, announced that it has been named a winner in the German Innovation Awards 2022, presented by the German Design Council.

Ormco Corporation , a global leader and innovator of orthodontic products and solutions, announces sole U.S. Distribution of the improved OrthoPulse® Gen.2 medical device.